World Pre-Clinical Imaging Market Growing at 15% CAGR to 2019

DALLAS, February 23, 2015 /PRNewswire/ --

Global Preclinical Imaging Market 2015-2019 and Pre-Clinical Imaging (In-VIVO) Market by Systems and Reagents with Global Forecasts to 2019 are the new 2015 diagnostics market research reports now available with LifeScienceIndustryResearch.com.

With a forecast of 15% CAGR for global pre-clinical imaging market during 2014 to 2019, the report considers revenue generated from sales of pre-clinical imaging systems to calculate the market size. Pre-clinical imaging systems are segmented based on the type of equipment such as Micro MRI, Micro-PET, Micro-CT, PAT, SPECT, Multi-modality, Optical Imaging and Ultrasound. The report presents the vendor landscape and a corresponding detailed analysis of the top seven vendors in the Global Pre-clinical Imaging market. The vendor landscape in this report focuses on the vendors that provide access to new and technologically advanced pre-clinical imaging systems. The report also outlines the challenges faced by the vendors and the market at large, as well as the key trends emerging in the market. Complete research is available at http://www.lifescienceindustryresearch.com/global-preclinical-imaging-market-2015-2019.html .

The Global Pre-clinical Imaging Market 2015-2019 research report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Pre-clinical Imaging market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. Companies like Aspect Imaging, Bioscan (Subsidiary of Trifoil Imaging), Bruker Corporation, Mediso Medical Imaging Systems, PerkinElmer, Siemens Healthcare, Thermo Fisher Scientific, Agilent Technologies, Capintec, Hitachi Medical, LI-COR Biosciences, Miltenyi Biotec GMBH, Naviscan, Positron, Promega and Quintiles are mentioned in this research available for purchase at http://www.lifescienceindustryresearch.com/purchase?rname=30581 .

The growth of the global preclinical imaging market is driven by factors such as development of technologically advanced hybrid preclinical imaging systems such as PET/CT, PET/MRI, and PET/SPECT/CT; growing acceptance of preclinical imaging as a legitimate drug development tool; and rising volume of preclinical research. In addition, emerging markets offering lucrative growth and departure of major companies from preclinical imaging systems market are creating new growth opportunities for the preclinical imaging systems and reagents manufacturers. Nonetheless, declining NIH (National Institutes of Health) funding for life science research, high implementation cost of preclinical imaging devices, and high cost and data requirements for bringing new imaging technology are the key reasons hampering the growth of preclinical imaging market.

According to the report titled Pre-Clinical Imaging (In-VIVO) Market by Systems and Reagents  (Optical Imaging, Micro-PET, Micro-SPECT, Micro-MRI, Micro-ultrasound, Computed Tomography, Photo Acoustic Imaging, Magnetic Particle Imaging, Multimodality Imaging) - Global Forecasts to 2019, global preclinical imaging market is estimated to grow at a CAGR of 6.0% from 2014 to 2019. Although mature markets (such as the U.S., Germany, France, and the U.K.) hold larger shares in the preclinical imaging market in 2014, the Asia-Pacific region is poised to grow at the highest CAGR of 8.2% in the next five years. Factors such as increased outsourcing of preclinical research activities to Asia-based CROs by big pharmaceutical and biotechnological companies, owing to low cost of research in these nations; and increased government funding for drug discovery and development activities in economically emerging counties are propelling the growth of the preclinical imaging market in Asia-Pacific region.

Geographically, North America (comprising the U.S. and Canada) commands the largest share of36.2% of the global preclinical imaging market in 2014, followed by Europe. The preclinical imaging market in North America is primarily driven by various factors high volume of preclinical research in this region, easy availability and accessibility of resources (such as radioactive tracers), and rising government funding for research and innovation in Canada.

However, declining funding budgets of the U.S. National Institutes of Health (NIH) for preclinical research studies and recent changes in the Canadian R&D tax credit program are negatively affecting the growth of preclinical imaging market in North America.

The global preclinical imaging market is highly fragmented and competitive with a large number of global and local manufacturers of preclinical imaging systems and reagents. As of 2013, the global preclinical imaging market was dominated by Perkin Elmer, Inc. (U.S.) and Bruker Corporation (U.S.), which together accounted for ~45% share of the market. New product launches, partnerships, agreements, collaborations, and geographic expansions were the major strategies adopted by most of the market players to achieve growth in the preclinical imaging market. Order a copy of this research at http://www.lifescienceindustryresearch.com/purchase?rname=1403 .

From an insight perspective, this research report has focused on various levels of analysis-industry analysis (industry trends, and Porter's five force model), market share analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the preclinical imaging systems and reagents market, high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.

Explore more reports on the diagnostics market at http://www.lifescienceindustryresearch.com/category/diagnostics .

About Us: 

Life Science Industry Research brings to you to the latest reports in market research on Biotechnology, Diagnostics, Healthcare, Medical Devices and Pharmaceuticals segments from leading research publishers across the globe. These reports also cover data and information on sub-segments and sectors under these life sciences categories.

Contact:  
Ritesh Tiwari / Siju K.
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252
Tel: +1-888-391-5441
E-mail: sales@lifescienceindustryresearch.com